The Magnum Ice Cream Company N.V. Ordinary Shares vs Vaxcyte Inc. Common Stock — how do they compare? The Magnum Ice Cream Company N.V. Ordinary Shares trades at $17.92 (market cap $10.72B), while Vaxcyte Inc. Common Stock trades at $67.37 (market cap $10.51B). The key difference: The Magnum Ice Cream Company N.V. Ordinary Shares and Vaxcyte Inc. Common Stock are close in size by market cap, and Vaxcyte Inc. Common Stock is trading nearer its 52-week high, The Magnum Ice Cream Company N.V. Ordinary Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold The Magnum Ice Cream Company N.V. Ordinary Shares for 0 Days and Vaxcyte Inc. Common Stock for 0 Days on average.
| MICC | PCVX | |
|---|---|---|
Market Cap | $10.72B | $10.51B |
Volume | 1,309,650 | 2,644,694 |
Sector | Consumer Staples | Health |
52-Week High | $20.42 | $73.82 |
52-Week Low | $13.06 | $40.32 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $14.14B | $9.14B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
The Magnum Ice Cream Company N.V. manufactures and sells ice cream and frozen desserts through brands including Magnum, Ben & Jerry's, Wall's, and Cornetto, distributing across roughly 80 countries.
Read more on MICC →Vaxcyte, Inc. is a clinical-stage vaccine company that engineers protein-based vaccines to prevent bacterial diseases such as invasive pneumococcal disease, using its proprietary cell-free protein synthesis platform to develop candidates including the pneumococcal conjugate vaccines VAX-31 and VAX-24.
Read more on PCVX →